021Fsgs16010
Research payments
$58,469
Through program year 2023, $58,469 in research payments was reported against 021Fsgs16010, across 48 payments, paid by Retrophin, Inc..
- Paid by
- Retrophin, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $58,469 | 48 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ali Poyan Mehr Boston, MA Named on 10 payments
- Ana Paredes South Miami, FL Named on 9 payments
- Kenneth Lieberman Hackensack, NJ Named on 6 payments
- Zeenat Bhat Ann Arbor, MI Named on 6 payments
- Gaia Muallem Philadelphia, PA Named on 6 payments
- Tarak Srivastava Kansas City, MO Named on 4 payments
- Katherine Tuttle Spokane, WA Named on 3 payments
- Amy Becker Corpus Christi, TX Named on 2 payments
- Elaine Kamil Los Angeles, CA Named on 1 payment
- Carlos Araya Orlando, FL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.